Atlas Trials

Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study

Clinical trial NCT02308644 · COMPLETED

Trial details

NCT number
NCT02308644
Sponsor
University of Sao Paulo
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2009-02-01
Primary completion
2011-12-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.